QNRX — Quoin Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Quoin Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -21.5 | -9.38 | -8.69 | -8.96 | -15.8 |
| Amortisation | |||||
| Non-Cash Items | 14.3 | 0.177 | 0.623 | 1.01 | 0.931 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.33 | 0.62 | 0.095 | -0.002 | 1.23 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -5.72 | -8.48 | -7.86 | -7.86 | -13.5 |
| Capital Expenditures | -0.625 | -0.25 | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -9.9 | 2.19 | -1.89 | -4.28 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.625 | -10.1 | 2.19 | -1.89 | -4.28 |
| Financing Cash Flow Items | 10.2 | 14.9 | -0.033 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13.5 | 14 | 5.22 | 11 | 18 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.16 | -4.62 | -0.459 | 1.22 | 0.195 |